Skip to main content
. 2020 Jul 8;10:11199. doi: 10.1038/s41598-020-67792-y

Table 1.

Pathogenic variants identified in this study.

Family
ID
Disease Genotyping
Method
Size of homozygous region, in Mb Chr Gene DNA pathogenic variant Predicted protein variant Reference sequence Previously reported SIFT PolyPhen
F1 LCA WES 14q11.2 RPGRIP1 c.[3113-3114delCT];[3113-3114delCT] p.[T1038Rfs*8]; T1038Rfs*8] NM_020366 This study
F2 LCA IROme 17p31.1 GUCY2D c.[2660 T > G];[2660 T > G] p.[V887G];[V887G] NM_000180

This study

and6

0 0.999
F3 LCA Asper 1p31.3 RPE65 c.[700C > T];[700C > T] p.[R234*];[R234*] NM_000329 29
F4 LCA WES 3q13.33 IQCB1 c.[994C > T];[994C > T] p.[R332*];[R332*] NM_001023570 30
F5 LCA WES 1q31.3 CRB1 c.[3542 + 1G > A];[3542 + 1G > A] NM_201253.2 This study
F6 CRD WES 40 1q31.3 CRB1 c.[2506C > A];[2506C > A] p.[P836T];[P836T] NM_201253.2 31 0.04 0.999
F7 CRD WES 124 1q31.3 CRB1 c.[ 2105A > G];[ 2105A > G] p.[Y702C];[Y702C] NM_201253.2 32 0 0.89
F8 CRD WES 10q23.1 CDHR1 c.[863-2_863-1delAG];[863-2_863-1delAG] NM_033100 This study
F9 CRD WES 8q22.1 C8ORF37 c.[470 + 1G > T];[470 + 1G > T] NM_177965 This study
F10 CRD WES 2p23.2 C2ORF71 c.[2756_2768del13];[ 2756_2768del13] p.[K919Tfs*2];[ K919Tfs*2] NM_001029883 33
F11 CRD WES 35 1p22.1 ABCA4 c.[1916A > G];[1916A > G] p.[Y639C];[Y639C] NM_000350.2 This study 0.01 1
F12 RP WES 77 1p22.1 ABCA4 c.[4139C > T];[4139C > T] p.[P1380L];[P1380L] NM_000350.2 34 0 0.716
F13 STGD WES 1p22.1 ABCA4 c.[1140 T > A];[1140 T > A] p.[N380K];[N380K] NM_000350.2 35 0.01 0.05
F14 STGD WES 1p22.1 ABCA4 c.[3259G > A];[3259G > A] p.[E1087K]; [E1087K] NM_000350.2 36 0 0.999
F15 CRD/STGD WES 1p22.1 ABCA4 c.[3259G > A];[3259G > A] p.[E1087K]; [E1087K] NM_000350.2 36 0 0.999
F16 RP WES 1p36.22 NMNAT1 c.[37G > A];[37G > A] p.[A13T];[A13T] NM_001297778.1 8 0 1
F17 RP WES 6p21.1 PRPH2 c.[133C > T];[ =] p.[L45F];[ =] NM_000322 37 0 0.991
F18 RP WES 2p15 FAM161A c.[685C > T];[685C > T] p.[R229*];[R229*] NM_001201543 38
F19 RP WES 16q21 CNGB1 c.[2293C > T];[2293C > T] p.[R765C];[R765C] NM_001297

This study

and 6

0 0.999
F20 RP WES 6q12 EYS c.(1766 + 1_1767-1)_(2023 + 1_2024-1)del NM_001292009 39
F21 RP WES 6q12 EYS c.[5928-2A > G];[5928-2A > G] NM_001292009 9
F22 SBB WES 2q31.1 BBS5 c.[214G > A];[214G > A] p.[G72S];[G72S] NM_152384.2 40 0 1
F23 SBB WES 48 2q31.1 BBS5 c.[123delA];[123delA] p.[G42Efs*11];[ G42Efs*11] NM_152384.2 41
F24 ACHM WES 119 2q11.2 CNGA3 c.[1114C > T];[1114C > T] p.[P372S];[P372S] NM_001298.2 42 0 0.989
F25 ACHM WES 87c 8q21.3 CNGB3 c.[1810C > T];[1810C > T] p.[R604*];[R604*] NM_019098.4 43
F26 CSNB WES 15q13.3 TRPM1 c.[3947 T > G];[3947 T > G] p.[L1316R];[L1316R] NM_002420.5 This study 0 0.075

Genes highlighted in bold harbor the novel pathogenic variants identified in this study.

LCA = Leber congenital amaurosis; RP = retinitis pigmentosa; CRD = cone-rod dystrophy; STGD = Stargardt disease; BBS = Bardet–Biedl syndrome; ACHM = Achromatopsia; CSNB = congenital stationary night blindness.